Proactive Investors - Run By Investors For Investors

Film completion contract firm FFI Holdings seeking AIM spotlight with listing move

FFI provides the financiers of film and television productions with contracts that such productions will be completed on time, on budget and to a basic pre-agreed specification
Hollywood sign
Since 2008, FFI, said it has issued completion contracts to films with gross production budgets estimated to be in excess of US$17bn

Film completion contracts firm FFI Holdings PLC is seeking a listing on London's AIM, according to a London Stock Exchange filing, although no further details of the move were provided.

FFI provides the financiers of film and television productions with contracts that such productions will be completed on time, on budget and to a basic pre-agreed specification.

Since 2008, the group, said it has issued completion contracts to all the leading financiers involved in the entertainment industry, unlocking funding for approximately 1,700 productions with gross production budgets estimated to be in excess of US$17bn.

The group was founded in London in 1950 and is now headquartered in Los Angeles, US, with 11 offices globally including in London, Stockholm, Toronto, New York, Johannesburg, Cologne and Shanghai.

The listing statement continued: "FFI is a trusted, iconic brand positioned at the centre of the independent film and television entertainment industry.”

It concluded: "This extensive network of longstanding relationships, together with FFI's deep knowledge and expertise of the film and television production process, has enabled it to secure a leading market share globally and a high level of repeat business from existing clients in its core completion contract business.”

View full FFI profile View Profile

FFI Holdings PLC Timeline

Related Articles

marketing
January 30 2019
“With the geopolitical landscape remaining in flux, clients are looking for greater certainty from their marketing programmes which our agencies and data businesses are proving able to provide"
Live Company
March 05 2019
Since listing on AIM in December 2017, the company has been pursuing an aggressive strategy of expansion and brand building that has paid off for the share price.
ipad
September 20 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use